CI
GSK icon

Conning Inc’s GSK GSK Stock Holding History

Conning Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-20,212
Closed -$896K – 586
2017
Q4 		$896K Sell
20,212
-1,360
-6% -$62.8K 0.03% 295
2017
Q3 		$1.09M Sell
21,572
-100
-0.5% -$5.07K 0.04% 261
2017
Q2 		$1.17M Buy
21,672
+16,900
+354% +$901K 0.04% 258
2017
Q1 		$251K Buy
+4,772
New +$242K 0.01% 541

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Conning Inc's GSK Position: Q1 2018 in Review

Conning Inc sold out of GSK (GSK) in Q1 2018, closing a stake of 20,212 shares — an estimated $896K sold.

Conning Inc first reported a position in GSK in Q1 2017 and held it in 4 quarters. The position peaked at $1.17M in Q2 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • Conning Inc reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • Conning Inc sold 20,212 GSK shares in Q1 2018, an estimated $896K.
  • Conning Inc first reported a position in GSK in Q1 2017 and held it in 4 quarters.
  • Conning Inc's GSK position peaked at $1.17M in Q2 2017.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on Conning Inc's 13F filing for Q1 2018, filed 4 May 2018.